Orphalan Drug Patent Portfolio
Orphalan owns 1 orange book drug protected by 4 US patents Given below is the list of Orphalan's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10988436 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | 03 May, 2039 | Active |
| US11072577 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | 03 May, 2039 | Active |
| US12358861 | Crystalline Form Of Triethylenetetramine Tetrahydrochloride And Its Pharmaceutical Use | 03 May, 2039 | Active |
| US12358862 | Crystalline Form Of Triethylenetetramine Tetrahydrochloride And Its Pharmaceutical Use | 03 May, 2039 | Active |
Latest Legal Activities on Orphalan's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orphalan.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 22 Jul, 2025 | US12358861 |
| Recordation of Patent Grant Mailed | 22 Jul, 2025 | US12358862 |
| Email Notification | 16 Jul, 2025 | US12358861 |
| Email Notification | 16 Jul, 2025 | US12358862 |
| Recordation of Patent eGrant | 15 Jul, 2025 | US12358862 |
| Mail Patent eGrant Notification | 15 Jul, 2025 | US12358861 |
| Patent eGrant Notification | 15 Jul, 2025 | US12358861 |
| Patent Issue Date Used in PTA Calculation | 15 Jul, 2025 | US12358861 |
| Patent Issue Date Used in PTA Calculation | 15 Jul, 2025 | US12358862 |
| Patent eGrant Notification | 15 Jul, 2025 | US12358862 |
| Recordation of Patent eGrant | 15 Jul, 2025 | US12358861 |
| Mail Patent eGrant Notification | 15 Jul, 2025 | US12358862 |
| Email Notification | 03 Jul, 2025 | US12358862 |
| Email Notification | 03 Jul, 2025 | US12358861 |
| Issue Notification Mailed | 02 Jul, 2025 | US12358862 |
Orphalan's Family Patents
Orphalan Drug List
Given below is the complete list of Orphalan's drugs and the patents protecting them.
1. Cuvrior
Cuvrior is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10988436 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
03 May, 2039
(13 years from now)
| Active |
| US11072577 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
03 May, 2039
(13 years from now)
| Active |
| US12358861 | Crystalline Form Of Triethylenetetramine Tetrahydrochloride And Its Pharmaceutical Use |
03 May, 2039
(13 years from now)
| Active |
| US12358862 | Crystalline Form Of Triethylenetetramine Tetrahydrochloride And Its Pharmaceutical Use |
03 May, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cuvrior's drug page